Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
7.73
+0.20 (2.66%)
At close: May 16, 2025, 4:00 PM
7.70
-0.03 (-0.39%)
After-hours: May 16, 2025, 7:45 PM EDT
GNOM Holdings List
As of May 14, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.92% |
2 | ILMN | Illumina, Inc. | 4.56% |
3 | NTRA | Natera, Inc. | 4.53% |
4 | QGEN | Qiagen N.V. | 4.33% |
5 | TECH | Bio-Techne Corporation | 4.25% |
6 | BMRN | BioMarin Pharmaceutical Inc. | 4.22% |
7 | RARE | Ultragenyx Pharmaceutical Inc. | 4.14% |
8 | RNA | Avidity Biosciences, Inc. | 4.12% |
9 | CRSP | CRISPR Therapeutics AG | 4.11% |
10 | MRNA | Moderna, Inc. | 4.03% |
11 | GH | Guardant Health, Inc. | 3.97% |
12 | VRTX | Vertex Pharmaceuticals Incorporated | 3.81% |
13 | LEGN | Legend Biotech Corporation | 3.61% |
14 | BNTX | BioNTech SE | 3.57% |
15 | VCYT | Veracyte, Inc. | 3.19% |
16 | SRPT | Sarepta Therapeutics, Inc. | 2.67% |
17 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.48% |
18 | TWST | Twist Bioscience Corporation | 2.42% |
19 | A | Agilent Technologies, Inc. | 2.36% |
20 | HKG: 1548 | Genscript Biotech Corporation | 2.19% |
21 | BEAM | Beam Therapeutics Inc. | 2.15% |
22 | LON: AZN | AstraZeneca PLC | 2.15% |
23 | WGS | GeneDx Holdings Corp. | 2.15% |
24 | GILD | Gilead Sciences, Inc. | 2.05% |
25 | BMY | Bristol-Myers Squibb Company | 2.02% |
26 | LLY | Eli Lilly and Company | 1.92% |
27 | TXG | 10x Genomics, Inc. | 1.35% |
28 | CDNA | CareDx, Inc | 1.20% |
29 | WVE | Wave Life Sciences Ltd. | 1.13% |
30 | NTLA | Intellia Therapeutics, Inc. | 1.12% |
31 | PRAX | Praxis Precision Medicines, Inc. | 1.02% |
32 | QURE | uniQure N.V. | 0.91% |
33 | RCKT | Rocket Pharmaceuticals, Inc. | 0.87% |
34 | VIR | Vir Biotechnology, Inc. | 0.57% |
35 | FLGT | Fulgent Genetics, Inc. | 0.57% |
36 | RGNX | REGENXBIO Inc. | 0.55% |
37 | STOK | Stoke Therapeutics, Inc. | 0.54% |
38 | MYGN | Myriad Genetics, Inc. | 0.49% |
39 | CVAC | CureVac N.V. | 0.46% |
40 | PSNL | Personalis, Inc. | 0.43% |
41 | PACB | Pacific Biosciences of California, Inc. | 0.42% |
42 | VERV | Verve Therapeutics, Inc. | 0.41% |
43 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.38% |
44 | SANA | Sana Biotechnology, Inc. | 0.34% |
45 | MRVI | Maravai LifeSciences Holdings, Inc. | 0.34% |
46 | CRGX | CARGO Therapeutics, Inc. | 0.28% |
47 | PRME | Prime Medicine, Inc. | 0.22% |
48 | ALLO | Allogene Therapeutics, Inc. | 0.20% |
49 | SGMO | Sangamo Therapeutics, Inc. | 0.19% |
50 | n/a | Cash | 0.09% |
As of May 14, 2025